Patient Counselling Information- (2020)- No.20. Fluorostradiol - (CERIANNA)- (May 2020)
Drug Name:
Patient Counselling Information- (2020)- No.20. Fluorostradiol - (CERIANNA)- (May 2020)
List Of Brands:
Indication Type Description:
Drug Interaction:
No..20. Fluoroestradiol F 18- (CERIANNA)-(May 2020)
PATIENT COUNSELING INFORMATION
Radiation Risk - Advise patients of the radiation risk of TAUVID
Pregnancy - Advise a pregnant woman of the potential risks of fetal exposure to radiation doses with TAUVID
Lactation - Advise a lactating woman to avoid breastfeeding for 4 hours after TAUVID administration in order to minimize radiation exposure to a breastfed infant
Manufactured for Avid Radiopharmaceuticals, a wholly-owned subsidiary of Eli Lilly and Company, Philadelphia, PA 19104 Copyright © 2020, Eli Lilly and Company. All rights reserved.